4//SEC Filing
Kelly David George 4
Accession 0000899243-21-025957
CIK 0001659323other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:06 PM ET
Size
5.6 KB
Accession
0000899243-21-025957
Insider Transaction Report
Form 4
Kelly David George
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-23+64,706→ 64,706 totalExercise: $2.01Exp: 2031-06-22→ Ordinary Shares (64,706 underlying)
Footnotes (1)
- [F1]Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on June 23, 2022.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001624670
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:06 PM ET
- Size
- 5.6 KB